Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 325 of 517 entries
View as:

A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06598735 Org: User:
Start: 09/30/24 End: 06/30/28 Due: 06/30/29

A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy

Phase: N/A Priority: Normal
NCT ID: NCT04400201 Org: User:
Start: 06/15/20 End: 10/30/20 Due: 10/30/21

A Trial of INS068 in Patients With Type 2 Diabetes Not Adequately Controlled With One or Two Oral Antidiabetics

Phase: N/A Priority: Normal
NCT ID: NCT04663282 Org: User:
Start: 02/04/21 End: 05/28/22 Due: 05/28/23

A Trial of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05459220 Org: User:
Start: 07/31/22 End: 02/28/23 Due: 02/28/24

A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Phase: N/A Priority: Normal
NCT ID: NCT05261646 Org: User:
Start: 04/15/22 End: 12/15/25 Due: 12/15/26

Study to Evaluate the Efficacy and Safety of Camrelizumab and Famitinib in Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04346381 Org: User:
Start: 06/05/20 End: 06/22/22 Due: 06/22/23

A Phase 1 Study of SHR-A1811 in Patients With Selected HER2 Expressing Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04513223 Org: User:
Start: 03/30/21 End: 12/31/24 Due: 12/31/25

Safety, Tolerability and Pharmacokinetics of the New Formulation SHR-1316 in Subjects With Advanced Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04979390 Org: User:
Start: 08/10/21 End: 07/31/22 Due: 07/31/23

A Phase 3 Study Comparing Carelizumab Plus Nab-paclitaxel and Apatinib, Carelizumab Plus Nab-paclitaxel, and Nab-paclitaxel in Patients With Advanced Triple Negative Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04335006 Org: User:
Start: 07/14/20 End: 04/14/23 Due: 04/14/24

A Pharmacokinetic Interaction Study Between Apatinib and Rosuvastatin or Metformin in Solid Tumor Subjects.

Phase: N/A Priority: Normal
NCT ID: NCT04428086 Org: User:
Start: 07/27/20 End: 08/22/21 Due: 08/22/22

A Phase II Study of HR070803 in the Treatment of Advanced Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05425472 Org: User:
Start: 07/27/22 End: 03/30/23 Due: 03/30/24

To Evaluate the Efficacy and Safety of RSS0393 Ointment in Patients With Plaque Psoriasis Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT06918743 Org: User:
Start: 04/30/25 End: 03/31/26 Due: 03/31/27

Safety and Pharmacokinetics of Fluzoparib in Healthy Subjects and Those With Impaired Kidney Function

Phase: N/A Priority: Normal
NCT ID: NCT05032235 Org: User:
Start: 11/09/21 End: 12/05/23 Due: 12/05/24

Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations

Phase: N/A Priority: Normal
NCT ID: NCT04688008 Org: User:
Start: 09/18/20 End: 10/30/20 Due: 10/30/21

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject

Phase: N/A Priority: Normal
NCT ID: NCT05147259 Org: User:
Start: 11/29/21 End: 02/16/22 Due: 02/16/23

Assessment of Gastric Emptying by SHR20004 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT06137469 Org: User:
Start: 12/26/23 End: 03/16/24 Due: 03/16/25

A Trial of Injectable SHR-A1811 in Combination With Pyrotinib or SHR-1316 in Subjects With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05482568 Org: User:
Start: 09/15/22 End: 12/30/24 Due: 12/30/25

Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations

Phase: N/A Priority: Normal
NCT ID: NCT06614153 Org: User:
Start: 05/16/23 End: 03/04/24 Due: 03/04/25

Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02353975 Org: User:
Start: 05/31/14 End: 09/30/14 Due: 09/30/15

Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04521192 Org: User:
Start: 05/06/19 End: 09/05/19 Due: 09/05/20

An Investigational Study of SHR3680 in Participants With Mild to Moderate Liver Impairment and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04631549 Org: User:
Start: 02/03/21 End: 07/31/23 Due: 07/31/24

Pharmacokinetic/Pharmacokinetic and Safety Studies of SHR4640 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05954169 Org: User:
Start: 08/07/23 End: 07/01/24 Due: 07/01/25

A Study to Evaluate the Efficacy and Safety of SHR0302 in Patients With Non-Radiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT05324631 Org: User:
Start: 08/16/22 End: 12/11/24 Due: 12/11/25

A Study of SHR-A1403 in Patients With Advanced Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT03856541 Org: User:
Start: 02/13/19 End: 05/07/20 Due: 05/07/21

The DDI Study of SP2086 and Valsartan

Phase: N/A Priority: Normal
NCT ID: NCT02817217 Org: User:
Start: 03/31/16 End: - Due: -